# SEP 2 1 2009

# 510K SUMMARY

This summary of $5 1 0 ( k )$ safety and effectiveness information is being submitted in accordance with the requirements of Safe Medical Devices Act of 1990 and 21 CFR 807.92

The assigned 510(k) number is: K092051

COMPANY/CONTACT.PERSON

Lisa Charter   
Manager, Regulatory Affairs   
Microgenics Corporation   
Thermo Fisher Scientific   
Specialty Diagnostics Division, CDx Fremont 46360 Fremont Blvd.   
Fremont, CA 94538   
(510) 979-5142 office   
(510) 979-5422 fax

DATE PREPARED

July 16, 2009

DEVICE NAME

# Trade Names:

Thermo Scientific $M A S ^ { \otimes }$ chemTRAK® H Liquid Assayed Chemistry Controls Thermo Scientific Moni-Trol® H Liquid Assayed Chemistry Controls

Common Names: chemTRAK® H Liquid Assayed Chemistry Controls Moni-Trol® H Liquid Assayed Chemistry Controls

Device Classification: Class I

Classification Panel: Quality Control Material (Assayed and Unassayed) for Clinical Chemistry

Regulation number: 21 CFR 862.1660

Product Code: JJY

INTENDED USE:

chemTRAK® H is intended for use as a consistent test sample of known concentration for-monitoring assay conditions in many clinical laboratory determinations. Include chemTRAK® H with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.

Moni-Trol® H is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include Moni-Trol® H with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.

# SUBSTANTIALLY EQUIVILANT PREDICATE DEVICE

Thermo Scientific $M A S ^ { \otimes }$ chemTRAK® H and Thermo Scientific Moni-Trol® H are substantially equivalent to the previously cleared MAS® chemTRAK® H, DADE® Moni-Trol® H and OLYMPUS Chemistry Control (K030942)

# DESCRIPTION OF DEVICE

This product is a liquid stable control material prepared from human serum. Analyte levels are adjusted with various animal extracts and other non-protein materials including drugs, drug metabolites and purified chemicals. Amylase, ALT/GPT, AST/GOT, CK and lipase are obtained from porcine tissue; alkaline phosphatase and GGT are from bovine tissue; LDH is from avian tissue. Preservatives and stabilizers are added to maintain product integrity.

Comparison of Technological Characteristics   

<table><tr><td>Comparison</td><td>Predicate Device, K030942</td><td>Modified Device, K092051 chemTRAK® H is intended for</td></tr><tr><td>Intended Use</td><td>chemTRAK® H is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include chemTRAK® H with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of</td><td>use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include chemTRAK® H with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of assuring consistent</td></tr><tr><td></td><td>assuring consistent performance of reagent and instrument. Moni-Trol® H is intended for use as a consistent test sample of known concentration for</td><td>performance of reagent and instrument. Moni-Trol® H is intended for use as a consistent test sample of known concentration for</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">monitoring assay conditions inmany clinical laboratorydeterminations. Include Moni-Tro!® H with patient serumspecimens when assaying forany of the listed constituents.The user can compareobservations with expectedranges as a means of assuringconsistent performance ofreagent and instrument.</td><td colspan="1" rowspan="1">monitoring assay conditions inmany clinical laboratorydeterminations. Include Moni-Trol® H with patient serumspecimens when assaying forany of the listed constituents.The user can compareobservations with expectedranges as a means of assuringconsistent performance ofreagent and instrument.</td></tr><tr><td colspan="1" rowspan="1">Description ofdeviceJ</td><td colspan="1" rowspan="1">This product is a liquid stablecontrol material prepared fromhuman serum. Analyte levelsare adjusted with various animalextracts and other non-proteinmaterials including drugs, drugmetabolites and purifiedchemicals. Amylase, ALT/GPT,AST/GOT, CK and lipase areobtained from porcine tissue;alkaline phosphatase and GGTare from bovine tissue; LDH isfrom avian tissue.Preservatives and stabilizersare added to maintain productintegrity.</td><td colspan="1" rowspan="1">This product is a liquid stablecontrol material prepared fromhuman serum. Analyte levelsare adjusted with various animalextracts and other non-proteinmaterials including drugs, drugmetabolites and purifiedchemicals. Amylase, ALT/GPT,AST/GOT, CK and lipase areobtained from porcine tissue;alkaline phosphatase and GGTare from bovine tissue; LDH isfrom avian tissue.Preservatives and stabilizersare added to maintain productintegrity.</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">This product is a liquid stablecontrol material prepared fromhuman serum.</td><td colspan="1" rowspan="1">This product is a liquid stablecontrol material prepared fromhuman serum.</td></tr><tr><td colspan="1" rowspan="1">StorageCondition</td><td colspan="1" rowspan="1">-20°</td><td colspan="1" rowspan="1">-20°</td></tr></table>

<table><tr><td colspan="1" rowspan="1">AnalyteList</td><td colspan="1" rowspan="1">Predicate DeviceK030942</td><td colspan="1" rowspan="1">Modified DeviceProposed Analytes(Modifications in bold)</td></tr><tr><td colspan="1" rowspan="7">−</td><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Acetaminophen</td></tr><tr><td colspan="1" rowspan="1">Acid Phosphatase*</td><td colspan="1" rowspan="1">Acid Phosphatase*</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">Albumin</td></tr><tr><td colspan="1" rowspan="1">Alkaline Phosphatase, ALP</td><td colspan="1" rowspan="1">Alkaline Phosphatase, ALP</td></tr><tr><td colspan="1" rowspan="1">Alanine Aminotransferase, ALT</td><td colspan="1" rowspan="1">Alanine Aminotransferase, ALT</td></tr><tr><td colspan="1" rowspan="1">Alpha-Fetoprotein, AFP*</td><td colspan="1" rowspan="1">Alpha-Fetoprotein, AFP*</td></tr><tr><td colspan="1" rowspan="1">Amikacin</td><td colspan="1" rowspan="1">Amikacin</td></tr><tr><td colspan="4" rowspan="87">Analyteist, Cont.hCGIron</td><td colspan="1" rowspan="2">Amylase</td></tr><tr><td colspan="1" rowspan="2">Amylase</td></tr><tr><td colspan="1" rowspan="2">Apolipoprotein A (APO A)*</td></tr><tr><td colspan="1" rowspan="2">Apolipoprotein A (APO A) </td></tr><tr><td colspan="1" rowspan="2">Apolipoprotein B (APO B)*</td></tr><tr><td colspan="1" rowspan="2">Apolipoprotein B (APO B)</td></tr><tr><td colspan="1" rowspan="2">Aspartate Aminotransferase, AST</td></tr><tr><td colspan="1" rowspan="2">Aspartate Aminotransferase, AST</td></tr><tr><td colspan="1" rowspan="2">Bilirubin, Direct</td></tr><tr><td colspan="1" rowspan="2">Bilirubin, Direct</td></tr><tr><td colspan="1" rowspan="2">Bilirubin, Total</td></tr><tr><td colspan="1" rowspan="2">Bilirubin, Total</td></tr><tr><td colspan="1" rowspan="2">Blood Urea Nitrogen, BUN</td></tr><tr><td colspan="1" rowspan="2">Blood Urea Nitrogen, BUN</td></tr><tr><td colspan="1" rowspan="2">Caffeine</td></tr><tr><td colspan="1" rowspan="2">Caffeine</td></tr><tr><td colspan="1" rowspan="2">Calcium</td></tr><tr><td colspan="1" rowspan="2">Calcium</td></tr><tr><td colspan="1" rowspan="2">Carbamazepine</td></tr><tr><td colspan="1" rowspan="2">Carbamazepine</td></tr><tr><td colspan="1" rowspan="2">Carbon Dioxide, CO2</td></tr><tr><td colspan="1" rowspan="2">CO2</td></tr><tr><td colspan="1" rowspan="2">C3 Compliment</td></tr><tr><td colspan="1" rowspan="2">C3 Complement*</td></tr><tr><td colspan="1" rowspan="2">C4 Compliment</td></tr><tr><td colspan="1" rowspan="2">C4 Complement*</td></tr><tr><td colspan="1" rowspan="2">C-Reactive Protein, CRP</td></tr><tr><td colspan="1" rowspan="2">C-Reactive Protein, CRP*</td></tr><tr><td colspan="1" rowspan="2">Chloride</td></tr><tr><td colspan="1" rowspan="2">Chloride</td></tr><tr><td colspan="1" rowspan="2">Cholesterol</td></tr><tr><td colspan="1" rowspan="2">Cholesterol          </td></tr><tr><td colspan="1" rowspan="2">Creatine Kinase, CK</td></tr><tr><td colspan="1" rowspan="2">Creatine Kinase, CK</td></tr><tr><td colspan="1" rowspan="2">Creatinine</td></tr><tr><td colspan="1" rowspan="2">Creatinine</td></tr><tr><td colspan="1" rowspan="2">Cyclosporine*</td></tr><tr><td colspan="1" rowspan="2">-</td></tr><tr><td colspan="1" rowspan="2">Digoxin</td></tr><tr><td colspan="1" rowspan="2">Digoxin</td></tr><tr><td colspan="2" rowspan="2">Disopyramide</td></tr><tr><td colspan="1" rowspan="2">Disopyramide</td></tr><tr><td colspan="2" rowspan="2">Ethanol</td></tr><tr><td colspan="1" rowspan="2">Ethanol</td></tr><tr><td colspan="2" rowspan="2">Ethosuximide</td></tr><tr><td colspan="1" rowspan="2">Ethosuximide</td></tr><tr><td colspan="2" rowspan="2">Ferritin</td></tr><tr><td colspan="1" rowspan="2">Ferritin*</td></tr><tr><td colspan="2" rowspan="2">Thiiodothyronine Free T3</td></tr><tr><td colspan="1" rowspan="2">Thiiodothyronine Free T3*</td></tr><tr><td colspan="2" rowspan="2">Thyroxine Free T4</td></tr><tr><td colspan="1" rowspan="2">Thyroxine Free T4*</td></tr><tr><td colspan="2" rowspan="2">Gamma Glutamyltransferase, GGT</td></tr><tr><td colspan="1" rowspan="2">Gamma Glutamyltransferase, GGT</td></tr><tr><td colspan="2" rowspan="2">Gentamicin</td></tr><tr><td colspan="1" rowspan="2">Gentamicin</td></tr><tr><td colspan="2" rowspan="3">Glutamate Dehydrogenase,GLDH*</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="3">Glutamate Dehydrogenase,GLDH*</td></tr><tr><td colspan="1" rowspan="3"></td></tr><tr><td colspan="2" rowspan="2">Glucose</td></tr><tr><td colspan="1" rowspan="2">Glucose</td></tr><tr><td colspan="2" rowspan="2">Haptoglobin*</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Haptoglobin*</td></tr><tr><td colspan="2" rowspan="3">Hydroxybutyrate Dehydrogenase,HBDH*</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="3">Hydroxybutyrate Dehydrogenase,HBDH*</td></tr><tr><td colspan="1" rowspan="3"></td></tr><tr><td colspan="3" rowspan="3">High Density LipoproteinCholesterol, HDL</td></tr><tr><td colspan="1" rowspan="3">High Density LipoproteinCholesterol, HDL</td></tr><tr><td colspan="1" rowspan="3"></td></tr><tr><td colspan="3" rowspan="3">Human Chorionic Gonadotrophin,hCG</td></tr><tr><td colspan="1" rowspan="3">Human Chorionic Gonadotrophin,hCG*</td></tr><tr><td colspan="1" rowspan="3"></td></tr><tr><td colspan="3" rowspan="2">Immunoglobulin A, IgA</td></tr><tr><td colspan="1" rowspan="2">Immunoglobulin A, IgA*</td></tr><tr><td colspan="3" rowspan="2">Immunoglobulin G, IgG</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Immunoglobulin G, IgG*</td></tr><tr><td colspan="3" rowspan="2">Immunoglobulin M, IgM</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Immunoglobulin M, IgM*</td></tr><tr><td colspan="3" rowspan="2">Iron</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Iron</td></tr><tr><td colspan="3" rowspan="2">Lactate Dehydrogenase, LDH</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">LDH</td></tr><tr><td colspan="3" rowspan="2">Lactic Acid</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Lactic Acid</td></tr><tr><td colspan="3" rowspan="3">Lidocaine</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="2">Lidocaine</td></tr><tr><td colspan="1" rowspan="1"></td></tr></table>

<table><tr><td rowspan=2 colspan=1>AnalyteList,Cont.</td><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>Lipase</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>Lipoprotein (LpA)</td></tr><tr><td rowspan=33 colspan=1></td><td rowspan=1 colspan=1>Lithium</td><td rowspan=1 colspan=1>Lithium</td></tr><tr><td rowspan=1 colspan=1>Low Density LipoproteinCholesterol, LDL</td><td rowspan=1 colspan=1>LDL-Cholesterol</td></tr><tr><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>Magnesium</td></tr><tr><td rowspan=1 colspan=1>Methotrexate</td><td rowspan=1 colspan=1>Methotrexate</td></tr><tr><td rowspan=1 colspan=1>N-Acetyiprocainamide, NAPA</td><td rowspan=1 colspan=1>N-Acetylprocainamide, NAPA</td></tr><tr><td rowspan=1 colspan=1>Osmolality</td><td rowspan=1 colspan=1>Osmolality</td></tr><tr><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>Phenobarbital</td></tr><tr><td rowspan=1 colspan=1>Phenytoin</td><td rowspan=1 colspan=1>Phenytoin</td></tr><tr><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>Phosphorus</td></tr><tr><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>Potassium</td></tr><tr><td rowspan=1 colspan=1>Prealbumin</td><td rowspan=1 colspan=1>Prealbumin</td></tr><tr><td rowspan=1 colspan=1>Primidone</td><td rowspan=1 colspan=1>Primidone</td></tr><tr><td rowspan=1 colspan=1>Procainamide</td><td rowspan=1 colspan=1>Procainamide</td></tr><tr><td rowspan=1 colspan=1>Prostate Specific Antigen, PSA</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Pseudocholinesterase, PCHE</td><td rowspan=1 colspan=1>Pseudocholinesterase</td></tr><tr><td rowspan=1 colspan=1>Quinidine</td><td rowspan=1 colspan=1>Quinidine</td></tr><tr><td rowspan=1 colspan=1>Salicylate</td><td rowspan=1 colspan=1>Salicylate</td></tr><tr><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>Sodium</td></tr><tr><td rowspan=1 colspan=1>Theophylline</td><td rowspan=1 colspan=1>Theophylline</td></tr><tr><td rowspan=1 colspan=1>Thyroid Stimulating Hormone, TSH</td><td rowspan=1 colspan=1>Thyroid Stimulating Hormone, TSH</td></tr><tr><td rowspan=1 colspan=1>Thyroxine, Total T4</td><td rowspan=1 colspan=1>Thyroxine, Total T4</td></tr><tr><td rowspan=1 colspan=1>Tobramycin           7</td><td rowspan=1 colspan=1>Tobramycin</td></tr><tr><td rowspan=1 colspan=1>Total Iron Binding Capacity, TIBC</td><td rowspan=1 colspan=1>Iron Binding Capacity, Total</td></tr><tr><td rowspan=1 colspan=1>Total Protein</td><td rowspan=1 colspan=1>Total Protein</td></tr><tr><td rowspan=1 colspan=1>Transferrin</td><td rowspan=1 colspan=1>Transferrin*</td></tr><tr><td rowspan=1 colspan=1>Tricyclic Antidepressants</td><td rowspan=1 colspan=1>Tricyclic Antidepressants</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>Triglycerides</td></tr><tr><td rowspan=1 colspan=1>Thiiodothyronine, Total T3</td><td rowspan=1 colspan=1>Thiiodothyronine, Total T3*</td></tr><tr><td rowspan=1 colspan=1>T-Uptake</td><td rowspan=1 colspan=1>T-Uptake</td></tr><tr><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>Uric Acid</td></tr><tr><td rowspan=1 colspan=1>Valproic Acid</td><td rowspan=1 colspan=1>Valproic Acid</td></tr><tr><td rowspan=1 colspan=1>Vancomycin</td><td rowspan=1 colspan=1>Vancomycin</td></tr><tr><td rowspan=1 colspan=1>Unsaturated Iron Binding Capacity(UIBC)</td><td rowspan=1 colspan=1>Unsaturated Iron Binding Capacity(UIBC)*</td></tr></table>

"Analytes are added, however no claims are made $\blacktriangle$ Analytes are not added, as found in the source material.

MicroGenics Corporation, Thermo Fisher Scientific c/o Ms. Lisa Charter Manager, Regulatory Affairs 46360 Fremont Blvd. Fremont, CA 94538

SEP 2 1 2009

Re: k092051 Trade Name: Thermo Scientific ${ \mathrm { { M A S @ } } }$ chemTRAK $\textsuperscript { \textregistered }$ H Liquid Assayed Chemistry Controls, Thermo Scientific Moni-Trol $\textsuperscript { \textregistered }$ H Liquid Assayed Chemistry Controls Regulation Number: 21 CFR $\ S 8 6 2 . 1 6 6 0$ Regulation Name: Quality control material (assayed and unassayed). Regulatory Class: Class I, reserved Product Codes: JJY Dated: July 1, 2009 Received: July 7, 2009

Dear Ms. Charter:

We have reviewed your Section $5 1 0 ( \mathbf { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, büt not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postniarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

4C.1

Courtney C. Harper, Ph.D.   
Acting Director   
Division of Chemistry and Toxicology . Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Enclosure

# Indication for Use

510(k) Number: K092051

# Device Name:

Thermo Scientific $M A S ^ { \otimes }$ chemTRAK® H Liquid Assayed Chemistry Controls Thermo Scientific Moni-Trol® H Liquid Assayed Chemistry Controls

Indication For Use:

chemTRAK® H is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include chemTRAK® H with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.

Moni-Trol® H is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include Moni-Tro ${ \mathfrak { P } } _ { \mathsf { H } }$ with patient serum specimens when assaying for any of the listed constituents. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.

Prescription Use And/Or Over the Counter Use   
(21 CFR Part 801 Subpart D) (21 CFR Part 801   
Subpart C)   
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE   
IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety OIVD)

![](images/6dfbf9fed7dff66382fb65a4100d70246d7eea6feb92e3615f5a00b9fece9f14.jpg)

Division Sign-Öff Office of In Vitro Diagnostic Device Evaluation and Safety 510(kk092051